ApexRF
Tissue. Circulation. Muscle. Explore the possibilities.
A multi-applicator platform combining controlled radiofrequency heating and electrical muscle stimulation. Apex Circulatory is designed for temporary improvement of local blood circulation; other applicators address soft tissue and muscle.
Your medical assessment determines suitability.
Understand the platform.
Bipolar RF & muscle stimulation platform
Manufacturer information- 01Apex Circulatory thermal applicator
- 02Tone electrical muscle stimulation
- 03Morpheus8 Burst fractional RF
Areas of application
Local circulation support · Soft-tissue contraction · Muscle stimulation
An informed choice.
What the evidence can tell you — and where its limits matter.
Sources checkedEvidence & expectations
Radiofrequency heating and electrical muscle stimulation are separate mechanisms. The FDA describes non-invasive body contouring as a change in localized shape or tone, not a treatment for obesity or a weight-loss method. Effects can be temporary and depend on the technology and site.[1]
RF microneedling introduces electrodes into tissue; it is different from external RF heating. Any proposed benefit needs to be considered alongside the actual needle depth, applicator and treated area. A platform name alone does not describe the procedure.[2]
Preparation & recovery
Discuss implants, previous procedures and any condition affecting the treatment area. Ask what sensations and visible changes to expect, and how the proposed applicator determines recovery and follow-up.[1]
Ask whether the proposed treatment punctures the skin, what anaesthesia and aftercare it needs and how to contact the clinician during healing. Do not infer recovery from an external-RF treatment.[2]
Risks & limitations
Energy-based procedures can cause pain, swelling, burns or unwanted tissue effects. Eligibility and risks depend on the modality and body site. Non-invasive does not mean risk-free or equivalent to surgery.[1]
In October 2025 the FDA highlighted reports of burns, scarring, fat loss, nerve damage and disfigurement with certain RF-microneedling uses. These are material risks to discuss, not effects that can be excluded by describing treatment as minimally invasive.[2]
Compare your options
Compare a skin-firmness goal with muscle activation and localized fat reduction. Tite, Tone and Transform are not interchangeable labels. Discuss the applicator’s intended purpose instead of assuming every mode produces all three effects.[1]
A surface-texture goal, a deeper soft-tissue goal and a surgical correction are different decisions. Compare the proposed depth and risks with fractional laser or non-invasive options before selecting a procedure.[3][4]
Different approaches to discuss
These links explain different targets. They are not personalised recommendations.
EvolveX TiteEvolveX ToneEvolveX TransformMorpheus8 RF microneedlingSources & further reading
- Regulatory safety informationNon-invasive body contouring technologiesFDA
- Regulatory safety informationPotential risks with certain uses of RF microneedlingFDA · 2025
- Systematic reviewMonopolar and bipolar radiofrequency for skin tightening: systematic reviewRohrich et al. · Plastic and Reconstructive Surgery · 2022
- Clinical study755 nm picosecond laser with a specialized optic for acne scarsBrauer et al. · JAMA Dermatology · 2015
- Manufacturer informationApexRF: platform informationInModeManufacturer information explains the platform or named protocol; it is not independent evidence of clinical benefit.
How we use evidence
A controlled trial compares interventions in defined groups; an uncontrolled cohort cannot, alone, establish causality. A review depends on the quality of its included studies. We distinguish these sources from manufacturer information and identify when findings do not directly apply to the platform or protocol.
The date records when sources were checked for this guide. It is not a statement of individual clinical review, product authorisation or confirmation of the clinic’s available configuration.
This guide supports a conversation with your clinician. It does not determine your suitability or replace individual aftercare instructions.
Regulatory sources describe their own jurisdictions; a US authorisation or warning does not determine a product’s legal status in Portugal.